| abstract |
Biologically active TR3-specific binding agents and methods for their use ar e disclosed. The biologically active TR3-specific binding agents are useful fo r inhibiting the proliferation of cells expressing TR3. These biologically active agents are particularly useful for treating T-cell mediated diseases such as graft-versus-host disease, organ rejection, tumor growth, autoimmunity, and inflammation. |